维普中文期刊产品整合服务
563篇 您的检索式:作者名="CHALASANI"
    题名 作者 年代 出处 被引量
1肛裂临床诊治指南(第三次修订)显示文摘“美国结直肠外科医师协会(American Societyof ColonandRectal Surgeons.ASCRS)”(协会)致力于推进结直肠和肛门疾病的相关理论以及预防和诊疗水平的提高,给患者提供优质的医疗服务。“标准委员会”由协会中在结直肠外科方面有显著专长的成员组成。该委员会的建立是为了引领国际结直肠和肛门疾病诊治的发展,以建立具有循证医学证据的临床诊疗指南。指南是涵盖性的,非指令性的,目的是为临床决策提供信息,而非具体的治疗方法。指南适用于所有相关的医护人员以及希望得到相应指南中疾病的相关诊治信息的患者。Farshid Araghizadeh ~ Robin Boushey Sridhar Chalasani George Chang Robert Cima Gary Dunn Daniel Feingold Philip Fleshner Daniel Geisler Jill Genua Sharon Gregorcyk Daniel Herzig Andreas Kaiser Ravin Kumar David Larson Steven Mills John Monson P. Terry Phang Feza Remzi David Rivadeneira Howard Ross Peter Senatore Elin Sigurdson Thomas Stahl Scott Steele Scott Strong Charles Tement Judith Trudel Madhulika Varnna Martin Weiser 丁义江(译) 皇甫少华(译) 丁曙晴(译) 2013中华胃肠外科杂志2013,16,7:70
2The diagnosis and management of non‐alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association显示文摘Naga Chalasani Zobair Younossi Joel E. Lavine Anna Mae Diehl Elizabeth M. Brunt Kenneth Cusi Michael Charlton Arun J. Sanyal 2012Hepatology2012,,6:5
3Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease显示文摘Sweta Tandra Matthew M. Yeh Elizabeth M. Brunt Raj Vuppalanchi Oscar W. Cummings Aynur ünalp-Arida Laura A. Wilson Naga Chalasani 2011Journal of Hepatology2011,,3:3
4Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease显示文摘Kris V. Kowdley Patricia Belt Laura A. Wilson Matthew M. Yeh Brent A. Neuschwander‐Tetri Naga Chalasani Arun J. Sanyal James E. Nelson 2011Hepatology2011,,:3
5Risk Factors for Idiosyncratic Drug-Induced Liver Injury显示文摘Naga Chalasani Einar Bj?rnsson 2010Gastroenterology2010,,7:2
6Drug-Induced Liver Injury Network (DILIN) Prospective Study: Rationale, Design and Conduct显示文摘Fontana Robert J Watkins Paul B Bonkovsky Herbert L Chalasani Naga Davern Timothy Serrano Jose Rochon James 2009Drug Safety2009,,1:2
7Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States显示文摘Naga Chalasani Robert J. Fontana Herbert L. Bonkovsky Paul B. Watkins Timothy Davern Jose Serrano Hongqiu Yang James Rochon 2008Gastroenterology2008,,6:2
8Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis显示文摘William R Kessler Oscar W Cummings George Eckert Naga Chalasani Lawrence Lumeng Paul Y Kwo 2004Clinical Gastroenterology and Hepatology2004,,7:2
9Nonalcoholic fatty liver disease and cardiovascular risk显示文摘Vijay Laxmi Misra Mouen Khashab Naga Chalasani 2009Current Gastroenterology Reports2009,,1:2
10Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity显示文摘Naga Chalasani Hisham Aljadhey Joe Kesterson Michael D. Murray Stephen D. Hall 2004Gastroenterology2004,,5:2
11Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis: endoscopic findings and results of therapy显示文摘Rungsun Rerknimitr Stuart Sherman Evan L. Fogel Cem Kalayci Lawrence Lumeng Naga Chalasani Paul Kwo Glen A. Lehman 2002Gastrointestinal Endoscopy2002,,2:2
12Epidemiology of Idiosyncratic Drug-Induced Liver Injury显示文摘Lauren Bell Naga Chalasani 2009Semin Liver Dis2009,,04:2
13Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States显示文摘Naga Chalasani Robert J. Fontana Herbert L. Bonkovsky Paul B. Watkins Timothy Davern Jose Serrano Hongqiu Yang James Rochon 2008Gastroenterology2008,,6:2
14Systemic inflammatory response syndrome caused by chronic salicylate intoxication显示文摘CHALASANI N ROMAN J JURADO R L 0,,05:1
15Nonalcoholic fatty liver dis- ease and nonalcoholic steatohepatitis:selected practical is-sues in their evaluation and management 显示文摘Vuppalanchi R Chalasani N 2009Hepatology2009,49,1:1
16Drug Induced Liver Injury Network Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States显示文摘Chalasani N Fontana PJ Bonkovsky HL 2008Gastroenterology2008,135,6:1
17Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer显示文摘Chalasani V Chin J L Izawa J I 2009Can Urol Assoc J2009,3,64:1
18The diagnosis and man-agement of non - alcoholic fatty liver disease : practice Guidelineby the American Association for the Study of Liver Diseases,A-merican College of Gastroenterology, and the American Gastroen-terological Association显示文摘Chalasani N Younossi Z Lavine J 2012Hepatology2012,55,6:1
19Hepatic cytochrome CVP2E1 activity in nondiabetie patients with nonalcoholic steato-hepatitis显示文摘Chalasani N Oorski JC Asghar MS 2003Hepatology2003,37,:1
20Stromal cell-derived factor-1 antagonizes slit/robo signaling in vivo显示文摘CHALASANI S H SABOL A XU H 2007J Neurosci2007,27,:1
返回顶部 每页显示:
共29页 首页 上一页 第1页 下一页 末页 /29 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费